H. Uzawa et al. / Tetrahedron 61 (2005) 5895–5905
5903
was treated with hydrazine acetate (27 mg, 0.30 mmol) in
DMF (4 mL) at 0 8C for 4 h. The mixture was then diluted
with CHCl3, and washed with brine. The organic layer was
dried (MgSO4), filtered and concentrated. Column chroma-
tography of the product on silica gel with 8:2 EtOAc–
hexane gave O-(2,3,4,6-tetra-O-acetyl-a-D-galactopyrano-
syl)-(1/4)-2,3,6-tri-O-acetyl-a/b-D-galactopyranoside
1H), 3.77 (br t, H-5, JZ6.8 Hz), 3.49–3.43 (m, –O–CH2–
(CH2)–, 1H), 3.41 (t, –CH2–Br, JZ6.8 Hz, 2H), 2.13 (Ac),
2.10 (Ac), 2.08 (Ac), 2.07 (Ac), 2.04 (2!Ac), 1.98 (Ac),
1.89–1.81 (m, –CH2–CH2Br, 2H), 1.61–1.54 (m, –OCH2–
CH2–, 2H), 1.44–1.26 (m, –(CH2)–, 12H); 13C NMR
(100 MHz, CDCl3): d 170.5, 170.4, 170.3, 170.2, 169.9,
169.5, 168.9, 101.1 (C-1), 99.2 (C-10), 72.6, 71.7, 69.9, 68.7,
68.4, 67.7, 67.2, 66.9, 61.8, 60.4, 33.9, 32.6, 29.3, 29.3,
29.2, 29.1, 28.6, 28.0, 25.7, 20.8, 20.6, 20.55, 20.53, 20.48;
IR (liquid film): 2931, 2856, 1750, 1434, 1371, 1225, 1180,
1132, 1070, 903, 600 cmK1. Anal. Calcd for C36H55O18Br:
C, 50.53; H, 6.48. Found C, 50.33; H, 6.35.
1
(88.5 mg, 93%). Selective H NMR (400 MHz, CDCl3): d
5.51 (d, HaK1, JZ3.2 Hz), 5.12 (dd, Hb-2, JZ8.0,
10.8 Hz), 5.03 (d, Hb-10, JZ3.6 Hz), 5.00 (d, Ha-10, JZ
4.0 Hz), 4.91 (dd, Hb-3, JZ2.4, 10.8 Hz), 4.70 (br d, Hb-1,
JZ7.6 Hz); 13C NMR (100 MHz, CDCl3): 98.9 (C-10), 95.5
(Cb-1), 90.4 (Ca-1); IR (KBr): 3469, 2973, 1751, 1660,
1437, 1374, 1235, 1157, 1131, 1070, 979, 908, 758,
600 cmK1; HRMS calcd for C26H36O18Na [MCNa]C
659.1800, found 659.1776.
4.1.9.4. Synthesis of 10-azidodecyl O-(2,3,4,6-tetra-O-
acetyl-a-D-galactopyranosyl)-(1/4)-2,3,6-tri-O-acetyl-
b-D-galactopyranoside. A solution of the 10-bromodecyl
glycoside (59 mg, 0.069 mmol) and NaN3 (8 mg,
0.12 mmol) in dry DMF (4 mL) was stirred at 80 8C for
5.5 h. The reaction mixture was then processed in the same
way described for the Section 4.1.4.1 to give 10-azidodecyl
O-(2,3,4,6-tetra-O-acetyl-a-D-galactopyranosyl)-(1/4)-
2,3,6-tri-O-acetyl-b-D-galactopyranoside (55 mg, 99%).
4.1.9.2. Synthesis of O-(2,3,4,6-tetra-O-acetyl-a-D-
galactopyranosyl)-(1/4)-2,3,6-tri-O-acetyl-a-D-galacto-
pyranosyl trichloroacetimidate. To a mixture of the above
selectively deacetylated compound (87 mg, 0.14 mmol) and
trichloroacetonitrile (400 mL, 4.0 mmol), 1,8-diazabicyclo
[5.4.0]undec-7-ene (30 mL, 0.20 mmol) was added at 0 8C
and stirred for 2 h. The reaction mixture was then subjected
to a silica gel column chromatography with 4:6 EtOAc–
hexane to afford O-(2,3,4,6-tetra-O-acetyl-a-D-galacto-
pyranosyl)-(1/4)-2,3,6-tri-O-acetyl-a-D-galactopyranosyl
trichloroacetimidate (95 mg, 90%). [a]D C148.68 (c 1.0,
CHCl3); 1H NMR (400 MHz, CDCl3): d 8.68 (s, NH), 6.61
(d, H-1, 3.6 Hz), 5.57 (dd, H-40, JZ1.2, 3.2 Hz), 5.42 (dd,
H-2, JZ3.6, 11.2 Hz), 5.38 (dd, H-30, JZ3.2, 11.2 Hz), 5.31
(dd, H-3, JZ2.8, 11.2 Hz), 5.24 (dd, H-20, JZ3.6, 11.2 Hz),
5.03 (d, H-10,03.2 Hz), 4.55–4.51 (m, H-50), 4.37–4.31 (m,
H-5 and H-6 ), 4.28 (br d, H-4, JZ2.4 Hz), 4.16–4.08
(m, H-6a, H-6b and H-60), 2.15 (Ac), 2.12 (2!Ac), 2.04
(Ac), 2.03 (2!Ac), 1.99 (Ac); 13C NMR (100 MHz,
CDCl3): d 170.5, 170.3, 170.1, 169.8, 169.7, 160.8
(C]NH), 109.7 (C-1), 98.9 (C-10), 93.6 (CCl3), 70.6, 69.4,
68.2, 67.7, 67.3, 67.1, 66.7, 61.8, 60.7, 20.9, 20.7, 20.6,
20.5, 20.4; IR (liquid film): 3320, 2977, 1748, 1677, 1434,
1
[a]D C70.48 (c 1.0, CHCl3); H NMR (400 MHz, CDCl3):
d 5.56 (dd, H-40, JZ1.2, 3.2 Hz), 5.39 (dd, H-30, JZ3.2,
10.8 Hz), 5.21–5.15 (m, H-20 and H-2), 5.00 (d, H-10, JZ
3.6 Hz), 4.81 (dd, H-3, JZ2.4, 11.2 Hz), 4.55–4.52 (m,
H-500), 4.48–4.44 (m, H-6 and H-1), 4.20–4.07 (m, H-60a,
H-6 b and H-6), 4.05 (br d, H-4, JZ2.0 Hz), 3.91–3.85
(m, –O–CH2–(CH2)–, 1H), 3.77 (br t, H-5, JZ6.8 Hz),
3.49–3.43 (m, –O–CH2–(CH2)–, 1H), 3.26 (t, –CH2–N3, JZ
6.8 Hz), 2.13 (Ac), 2.10 (Ac), 2.08 (Ac), 2.07 (Ac), 2.04
(2!Ac), 1.98 (Ac), 1.63–1.54 (m, –(CH2)–, 4H), 1.38–1.28
(m, –(CH2)–, 12H); 13C NMR (100 MHz, CDCl3): d 170.5,
170.4, 170.3, 170.2, 169.9, 169.5, 168.9, 101.0 (C-1), 99.2
(C-10), 72.6, 71.7, 69.8, 68.6, 68.4, 67.7, 67.2, 66.9, 61.8,
60.3, 51.3 (–CH2N3), 29.3, 29.2, 29.1, 28.9, 28.6, 26.5, 25.6,
20.8, 20.6, 20.51, 20.48, 20.43; IR (liquid film): 2933, 2857,
2098, 1751, 1371, 1225, 1133, 1067, 903, 668 cmK1. Anal.
Calcd for C36H55O18N3: C, 52.87; H, 6.78; N, 5.14. Found:
C, 52.59; H, 6.42; N, 4.77.
1372, 1225, 1134, 1068, 971, 904, 837, 797, 752, 644 cmK1
.
4.1.9.3. Synthesis of 10-bromodecyl O-(2,3,4,6-tetra-O-
acetyl-a-D-galactopyranosyl)-(1/4)-2,3,6-tri-O-acetyl-b-
D-galactopyranoside. A solution of the above trichloro-
acetimidate compound (61 mg, 0.077 mmol) and 10-bromo-
1-decanol (182 mg, 0.76 mmol) in dry CH2Cl2 (2 mL)
4.1.9.5. Synthesis of 9. A mixture of the above azide
compound (55 mg, 0.068 mmol) and a catalytic amount of
Pd(OH)2 (ca. 5 mg) was stirred in MeOH (5 mL) at room
temperature under hydrogen atmosphere for 3 h. The reac-
tion mixture was then processed in the same way described
for compound 5 to give 9 (49 mg, 91%). [a]D C70.48 (c 1.0,
˚
containing freshly activated 4 A-MS (400 mg) was stirred
1
for 1 h at 25 8C under N2. The reaction mixture was then
cooled to 0 8C and Me3SiOTf (9 mL, 0.05 mmol) was added.
The mixture was stirred at 0 8C for 2.5 h and then
triethylamine was added. The mixture was filtered through
a Celite pad, then diluted with CHCl3 and washed with satd
aq NaHCO3, water, respectively. The organic layer was
dried (MgSO4), filtered and concentrated. Column chromato-
graphy of the product on silica gel with 4:6 EtOAc–hexane
afforded 10-bromodecyl glycoside (59 mg, 90%); [a]D
C60.38 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3): d 5.56
(dd, H-40, JZ1.2, 3.2 Hz), 5.39 (dd, H-30, JZ3.6, 11.2 Hz),
5.21–5.15 (m, H-20 and H-2), 5.00 (d, H-10, JZ3.6 Hz), 4.81
(dd, H-3, JZ2.8, 10.8 Hz), 4.55–4.52 (0m, H-500), 4.48–4.44
(m, H-6 and H-1), 4.20–4.07 (m, H-6 a, H-6 b and H-6),
4.05 (br d, H-4, JZ2.4 Hz), 3.91–3.85 (m, –O–CH2–(CH2)–,
CH3OH); H NMR (400 MHz, CD3OD): d 5.54 (dd, H-40,
JZ1.2, 3.2 Hz), 5.40 (dd, H-30,0JZ3.2, 11.2 Hz), 5.22–5.14
(m, H-20 and H-2), 5.06 (d, H-1 , 4.0 Hz), 5.01 (dd, H-3, JZ
2.4, 10.8 Hz), 4.63 (d, H-1, JZ8.0 Hz), 4.58–4.54 (m, H-50),
4.43 (dd, H-6, JZ7.2, 11.2 Hz), 4.21–4.11 (m, H-4, H-60a,
H-60b and H-6), 4.00–3.96 (m, H-5), 3.90–3.85 (m, –O–
CH2–(CH2)–, 1H), 3.57–3.51 (m, –O–CH2–(CH2)–, 1H),
2.92 (t, –CH2–N3, JZ7.6 Hz, 2H), 2.13 (Ac), 2.11 (Ac),
2.08 (Ac), 2.05 (Ac), 2.04 (Ac), 2.02 (Ac), 1.96 (Ac), 1.69–
1.33 (m, –(CH2)–, 16H); 13C NMR (100 MHz, CD3OD): d
172.2, 172.0, 171.9, 171.6, 171.3, 102.3, 100.4, 78.5, 73.8,
73.5, 71.0, 70.6, 69.6, 69.5, 69.0, 68.4, 64.1, 62.0, 40.8,
30.6, 30.5, 30.4, 30.3, 30.2, 28.5, 27.4, 27.0, 21.0, 20.81,
20.76, 20.7, 20.6, 20.5; IR (KBr): 3458, 2935, 2859, 1753,
1631, 1435, 1373, 1230, 1134, 1072, 904, 601 cmK1
;